Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.

Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.
复制标题

HPV疫苗接种率和宫颈癌筛查率低:COVID-19大流行背景下的挑战和机遇。

DOI:
10.1016/j.ypmed.2022.107070
复制
发表时间:
2022-06
影响因子:
5.1
通讯作者:
Perkins, Rebecca B.
Perkins, Rebecca B.
中科院分区:
医学2区
文献类型:
--
作者:
Smith, Debi L.;Perkins, Rebecca B.

文献摘要

参考文献

被引文献

相似文献

这篇特邀评论讨论了理查兹等人的文章,描述了2018年不同保险计划的参保者按时接种HPV疫苗和宫颈癌筛查的差异。该评论重点关注HPV疫苗接种率低和所有部门宫颈癌筛查率下降的更大问题。我们概述了COVID-19大流行对HPV疫苗接种和宫颈癌筛查带来的挑战,并讨论了改善宫颈癌预防的机会。
This invited commentary discusses the article by Richards et al. describing differences in rates of on-time HPV vaccination and cervical cancer screening in 2018 among enrollees in different insurance plans. The commentary focuses on the larger problem of low vaccination HPV rates and decreasing cervical cancer screening rates seen across all sectors. We outline challenges posed by the COVID-19 pandemic on HPV vaccination and cervical cancer screening, and discuss opportunities to improve cervical cancer prevention.
DOI: 10.1001/jamanetworkopen.2021.43582
发表时间: 2022-01-04
期刊: JAMA network open
影响因子: 13.8
作者:
Suk R;Hong YR;Rajan SS;Xie Z;Zhu Y;Spencer JC
通讯作者: Spencer JC
评估 1999-2017 年 HPV 疫苗接种对美国 15-29 岁女性宫颈癌发病率的影响:一项生态学研究。
DOI: 10.1158/1055-9965.epi-20-0846
发表时间: 2021-01
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者:
Mix JM;Van Dyne EA;Saraiya M;Hallowell BD;Thomas CC
通讯作者: Thomas CC
DOI: 10.1097/01.aog.0000443278.06393.d6
发表时间: 2014-02-01
影响因子: 7.2
作者:
通讯作者: --
DOI: 10.1089/biores.2018.0040
发表时间: 2019-04-30
影响因子: --
作者:
Bishop, Erin;Katz, Mira L.;Reiter, Paul L.
通讯作者: Reiter, Paul L.
DOI: 10.1016/s0140-6736(20)30068-4
发表时间: 2020-02-22
期刊: LANCET
影响因子: 168.9
作者:
Brisson, Marc;Kim, Jane J.;Hutubessy, Raymond
通讯作者: Hutubessy, Raymond